Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles.

autophagy breast cancer drug resistance nanomaterial nanoparticles

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 24 01 2023
accepted: 19 04 2023
medline: 22 5 2023
pubmed: 22 5 2023
entrez: 22 5 2023
Statut: epublish

Résumé

Autophagy regenerates cellular nutrients, recycles metabolites, and maintains hemostasis through multistep signaling pathways, in conjunction with lysosomal degradation mechanisms. In tumor cells, autophagy has been shown to play a dual role as both tumor suppressor and tumor promoter, leading to the discovery of new therapeutic strategies for cancer. Therefore, regulation of autophagy is essential during cancer progression. In this regard, the use of nanoparticles (NPs) is a promising technique in the clinic to modulate autophagy pathways. Here, we summarized the importance of breast cancer worldwide, and we discussed its classification, current treatment strategies, and the strengths and weaknesses of available treatments. We have also described the application of NPs and nanocarriers (NCs) in breast cancer treatment and their capability to modulate autophagy. Then the advantages and disadvantaged of NPs in cancer therapy along with future applications will be disscussed. The purpose of this review is to provide up-to-date information on NPs used in breast cancer treatment and their impacts on autophagy pathways for researchers.

Identifiants

pubmed: 37213283
doi: 10.3389/fonc.2023.1150492
pmc: PMC10196239
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1150492

Informations de copyright

Copyright © 2023 Gharoonpour, Simiyari, Yousefzadeh, Badragheh and Rahmati.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Natl Cancer Inst. 1973 Jan;50(1):21-42
pubmed: 4571238
Bioorg Med Chem Lett. 2019 Jul 1;29(13):1549-1554
pubmed: 31054863
Cancer Lett. 2018 Oct 28;435:32-43
pubmed: 30055290
J Cell Sci. 2006 Sep 15;119(Pt 18):3888-900
pubmed: 16940348
Int J Nanomedicine. 2017 Mar 07;12:1815-1825
pubmed: 28331307
Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1035-52
pubmed: 18680439
Oncogene. 2018 Mar;37(9):1142-1158
pubmed: 29255248
J Med Chem. 2015 Jan 8;58(1):376-400
pubmed: 25402320
Cancer Lett. 2012 Dec 30;326(2):143-54
pubmed: 22863539
Life Sci. 2020 May 1;248:117466
pubmed: 32101760
J Nanobiotechnology. 2021 Oct 15;19(1):322
pubmed: 34654430
Annu Rev Genet. 2009;43:67-93
pubmed: 19653858
Biol Rev Camb Philos Soc. 2009 Aug;84(3):431-48
pubmed: 19659885
Biomaterials. 2015 Apr;48:1-15
pubmed: 25701027
Int J Nanomedicine. 2012;7:5781-92
pubmed: 23185118
Nanomedicine. 2015 Oct;11(7):1603-11
pubmed: 25989200
J Huazhong Univ Sci Technolog Med Sci. 2016 Feb;36(1):14-20
pubmed: 26838734
J Control Release. 2015 Dec 28;220(Pt B):571-83
pubmed: 26348388
Cell Calcium. 2020 Dec;92:102308
pubmed: 33096320
J Biomed Mater Res A. 2021 Sep;109(9):1693-1700
pubmed: 33719211
Pharm Res. 2016 Oct;33(10):2373-87
pubmed: 27299311
Nanoscale Res Lett. 2021 Dec 5;16(1):173
pubmed: 34866166
ACS Appl Mater Interfaces. 2018 Aug 22;10(33):27701-27711
pubmed: 30048114
Biochem Pharmacol. 2012 Mar 15;83(6):747-57
pubmed: 22226932
Lancet. 1989 Jul 22;2(8656):227
pubmed: 2568561
Theranostics. 2015 Aug 09;5(11):1233-48
pubmed: 26379789
Autophagy. 2014;10(11):2036-52
pubmed: 25483966
Clin Chem. 2006 Mar;52(3):345-51
pubmed: 16410341
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33925129
Pharmacol Res. 2022 Mar;177:106114
pubmed: 35124206
Int J Cancer. 2023 Feb 15;152(4):600-615
pubmed: 36279903
Nanomedicine (Lond). 2007 Oct;2(5):681-93
pubmed: 17976030
Autophagy. 2011 Jun;7(6):645-6
pubmed: 21460623
Colloids Surf B Biointerfaces. 2012 Jun 15;95:195-200
pubmed: 22445746
J Clin Invest. 2003 Dec;112(12):1809-20
pubmed: 14638851
Asian Pac J Cancer Prev. 2012;13(4):1617-20
pubmed: 22799377
FASEB Bioadv. 2019 Sep 30;1(10):639-660
pubmed: 32123812
Br J Nurs. 1995 Apr 27-May 10;4(8):431-2, 434, 436-9
pubmed: 7772978
Autophagy. 2019 Jan;15(1):4-33
pubmed: 30160607
Autophagy. 2013 Nov 1;9(11):1710-9
pubmed: 24121708
Int J Nanomedicine. 2015 Oct 22;10:6615-32
pubmed: 26543365
Oncotarget. 2017 Dec 23;9(11):9685-9705
pubmed: 29515763
Nat Cell Biol. 2011 Feb;13(2):132-41
pubmed: 21258367
Cancer Biol Ther. 2004 Jan;3(1):4-12
pubmed: 14726654
Autophagy. 2020 Jun;16(6):1164-1165
pubmed: 32267786
PLoS One. 2017 May 22;12(5):e0177694
pubmed: 28531218
J Cell Sci. 2017 Apr 1;130(7):1209-1216
pubmed: 28302910
Mol Cell. 2014 Jul 17;55(2):238-52
pubmed: 24954904
Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):49-57
pubmed: 27842219
Oncogene. 2019 Jan;38(4):581-595
pubmed: 30166591
Nat Commun. 2018 May 22;9(1):1944
pubmed: 29789598
Cell Mol Life Sci. 2019 Apr;76(7):1215-1242
pubmed: 30483817
Eur J Pharm Biopharm. 2000 Jul;50(1):161-77
pubmed: 10840199
Neoplasma. 1997;44(2):127-32
pubmed: 9201293
Breast Cancer Res Treat. 2008 Dec;112(3):389-403
pubmed: 18172760
Methods Enzymol. 2017;587:247-255
pubmed: 28253959
Pharmaceutics. 2022 Feb 10;14(2):
pubmed: 35214127
Autophagy. 2012 Nov;8(11):1643-56
pubmed: 22874552
Pharmaceuticals (Basel). 2021 Aug 24;14(9):
pubmed: 34577537
Lancet. 2005 May 14-20;365(9472):1687-717
pubmed: 15894097
Am J Cancer Res. 2013 Jun 20;3(3):251-65
pubmed: 23841025
Cell Death Differ. 2005 Nov;12 Suppl 2:1542-52
pubmed: 16247502
BMC Cancer. 2016 Sep 29;16(1):762
pubmed: 27687594
Nat Rev Cancer. 2017 Jan;17(1):20-37
pubmed: 27834398
J Natl Cancer Inst. 2002 Apr 17;94(8):606-16
pubmed: 11959894
Biochim Biophys Acta. 2014 Jan;1840(1):1-9
pubmed: 23962629
Nat Cancer. 2021 Jul;2(7):680-692
pubmed: 35121946
Lancet Oncol. 2012 Aug;13(8):790-801
pubmed: 22658655
Oncol Lett. 2022 Apr;23(4):138
pubmed: 35317027
J Control Release. 2017 Apr 28;252:28-49
pubmed: 28279798
ACS Nano. 2011 Nov 22;5(11):8629-39
pubmed: 21974862
Molecules. 2016 Jul 22;21(7):
pubmed: 27455225
Int J Mol Med. 2013 Jun;31(6):1449-56
pubmed: 23588698
PLoS Genet. 2020 Jan 10;16(1):e1008558
pubmed: 31923184
Angew Chem Int Ed Engl. 2015 Jan 19;54(4):1365-8
pubmed: 25483403
Int J Mol Sci. 2023 Jan 20;24(3):
pubmed: 36768363
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:949-959
pubmed: 28576071
Horm Mol Biol Clin Investig. 2020 Oct 21;41(4):
pubmed: 33079703
J Hematol Oncol. 2020 Nov 25;13(1):159
pubmed: 33239065
Front Pharmacol. 2020 May 29;11:787
pubmed: 32547395
Apoptosis. 2016 Apr;21(4):473-88
pubmed: 26767845
Biomaterials. 2016 Oct;103:44-55
pubmed: 27376558
Antioxid Redox Signal. 2011 Jun;14(11):2201-14
pubmed: 20712405
Biomed Microdevices. 2009 Feb;11(1):49-63
pubmed: 18663578
Cell Res. 2014 Jan;24(1):24-41
pubmed: 24366339
ACS Appl Mater Interfaces. 2019 Sep 11;11(36):32729-32738
pubmed: 31415145
Breast Cancer Res. 2020 Jun 9;22(1):61
pubmed: 32517735
Curr Drug Targets. 2016;17(2):206-28
pubmed: 26201484
Anticancer Res. 2018 Feb;38(2):617-621
pubmed: 29374684
Int J Pharm. 2008 Sep 1;361(1-2):239-44
pubmed: 18586075
CA Cancer J Clin. 2017 Jul 8;67(4):290-303
pubmed: 28294295
Br J Radiol. 2022 Feb 1;95(1130):20211033
pubmed: 34905391
Cells. 2021 Jun 09;10(6):
pubmed: 34207792
Nat Commun. 2018 Jan 9;9(1):130
pubmed: 29317633
Pharm Nanotechnol. 2018;6(2):94-110
pubmed: 29866028
FASEB J. 2018 Mar;32(3):1222-1235
pubmed: 29127189
J Korean Med Sci. 2007 Feb;22(1):117-21
pubmed: 17297263
Biochim Biophys Acta. 2015 Feb;1850(2):401-10
pubmed: 25445714
J Cancer Res Ther. 2014 Jul-Sep;10(3):506-11
pubmed: 25313729
J Cell Sci. 2004 Sep 15;117(Pt 20):4837-48
pubmed: 15340014
Semin Immunol. 2017 Dec;34:25-32
pubmed: 28985993
Nanomaterials (Basel). 2018 Oct 09;8(10):
pubmed: 30304783
Nat Rev Cancer. 2017 Sep;17(9):528-542
pubmed: 28751651
Adv Healthc Mater. 2018 Jun;7(11):e1800121
pubmed: 29582583
Clin Transl Oncol. 2021 Apr;23(4):738-749
pubmed: 32734535
J Cell Biol. 2005 Nov 21;171(4):603-14
pubmed: 16286508
Theranostics. 2019 Jan 25;9(3):837-852
pubmed: 30809312
Antioxid Redox Signal. 2014 Jan 20;20(3):460-73
pubmed: 23725295
Clin Chim Acta. 2006 Jan;363(1-2):187-96
pubmed: 16126188
Mol Cancer. 2020 Jan 22;19(1):12
pubmed: 31969156
J Control Release. 2020 Oct 10;326:628-647
pubmed: 32653502
Cancer Res. 2006 Jul 1;66(13):6732-40
pubmed: 16818648
Am Soc Clin Oncol Educ Book. 2018 May 23;38:457-467
pubmed: 30231399
Breast. 2022 Dec;66:15-23
pubmed: 36084384
Trends Biotechnol. 2000 Oct;18(10):412-20
pubmed: 10998507
Biochem Biophys Res Commun. 1988 Feb 29;151(1):40-7
pubmed: 3126737
Biochem Biophys Res Commun. 2013 Mar 1;432(1):5-9
pubmed: 23395679
Cell. 2012 Dec 7;151(6):1256-69
pubmed: 23217709
Nanoscale. 2018 Jul 5;10(25):11719-11731
pubmed: 29917035
Sci Rep. 2020 Oct 22;10(1):18124
pubmed: 33093596
PLoS One. 2021 Aug 18;16(8):e0256320
pubmed: 34407152
Essays Biochem. 2013;55:65-78
pubmed: 24070472
J Natl Cancer Inst. 2002 Jan 16;94(2):116-28
pubmed: 11792750
Nat Rev Drug Discov. 2017 Jul;16(7):487-511
pubmed: 28529316
Nano Res. 2020 Jun;13(6):1693-1703
pubmed: 33304449
Chem Commun (Camb). 2011 May 14;47(18):5235-7
pubmed: 21451845
Colloids Surf B Biointerfaces. 2020 Feb;186:110603
pubmed: 31846892
Bioeng Transl Med. 2019 Sep 05;4(3):e10143
pubmed: 31572799
Nature. 1999 Dec 9;402(6762):672-6
pubmed: 10604474
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Annu Rev Biomed Eng. 2007;9:257-88
pubmed: 17439359
Pharmacol Res. 2021 Jan;163:105320
pubmed: 33271295
Adv Mater. 2015 Apr 24;27(16):2627-34
pubmed: 25786652
Oncotarget. 2016 Apr 19;7(16):21235-46
pubmed: 26788909
Nat Commun. 2017 Jun 06;8:15180
pubmed: 28585546
Cell Res. 2014 Jan;24(1):92-104
pubmed: 24281265
Autophagy. 2018;14(2):243-251
pubmed: 29165043
Cell Death Dis. 2013 Oct 31;4:e892
pubmed: 24176850
Int J Pharm. 2020 Jul 30;585:119465
pubmed: 32497731
Nat Biotechnol. 2007 Oct;25(10):1165-70
pubmed: 17891134
Theranostics. 2018 Jan 1;8(3):830-845
pubmed: 29344310
ACS Nano. 2015 Mar 24;9(3):3169-77
pubmed: 25715979
Mol Biol Rep. 2020 Nov;47(11):9021-9032
pubmed: 33034883
Pharmacol Ther. 2018 Nov;191:43-49
pubmed: 29932886
Cancers (Basel). 2021 Oct 22;13(21):
pubmed: 34771481
Small. 2021 Sep;17(38):e2102295
pubmed: 34365730
Autophagy. 2010 Oct;6(7):838-54
pubmed: 20505317
World J Gastroenterol. 2018 Nov 7;24(41):4643-4651
pubmed: 30416312
Kaohsiung J Med Sci. 2021 Jan;37(1):12-19
pubmed: 33021078
Colloids Surf B Biointerfaces. 2015 Dec 1;136:514-26
pubmed: 26454541

Auteurs

Azar Gharoonpour (A)

Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Dorsa Simiyari (D)

Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Ali Yousefzadeh (A)

Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Fatemeh Badragheh (F)

Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Marveh Rahmati (M)

Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Classifications MeSH